Kohls Corp Stock Price, News & Analysis

Kohl's Corporation (NYSE: KSS) issued a statement in response to Institutional Shareholder Services (ISS) regarding the upcoming director election. ISS concluded that a change in board control is unwarranted, citing Kohl’s resilient performance amid a challenging retail landscape. Kohl’s urged shareholders to vote for its nominated directors, emphasizing the lack of M&A or public board experience among dissident nominees from Macellum Advisors. The board's extensive experience is deemed crucial for maintaining value during strategic reviews.

Kohl's Corporation (NYSE: KSS) is urging shareholders to vote for its slate of 13 director nominees in response to a proxy contest led by Macellum. The Company emphasizes the experience and qualifications of its Board, highlighting recent additions that aim to maximize shareholder value. Kohl's has undertaken a strategic review process with Goldman Sachs, engaging over 25 bidders. Under the current strategy, Kohl's achieved record EPS and doubled its annual dividend to $2 per share for 2022. Kohl's warns against the inexperienced slate proposed by Macellum, questioning their ability to deliver sustainable value.

Macellum Advisors, holding nearly 5% of Kohl's Corporation (KSS), issued a rebuttal presentation challenging the incumbent Board's claims about the company's performance from its April 21 presentation. Macellum argues that Kohl's has underperformed against its peers and faces significant risks if there is no change in leadership or a fair sale of the company before the Annual Meeting. Macellum is urging shareholders to vote for its 10 independent nominees to drive accountability and improve strategic planning.

Kohl's Corporation (NYSE: KSS) has detailed its progress in maximizing shareholder value through a robust strategy and a strong Board of Directors. The Company reported record EPS and significant capital returns, including over $1.5 billion in share repurchases and dividends since October 2020. Highlights include a partnership with Sephora and a capital allocation strategy that includes a 100% dividend increase and a new $3 billion share repurchase authorization. Kohl's is also evaluating expressions of interest for potential buyouts, engaging Goldman Sachs in the process while asserting the inadequacy of Macellum Advisors' board nominees.

Macellum Advisors, holding nearly 5% of Kohl’s Corporation (NYSE: KSS), urges shareholders to vote for its 10 independent nominees using the WHITE proxy card. In a presentation, Macellum highlights Kohl's ongoing underperformance, citing a 13% drop in share price and significant market share losses. They criticize the management’s strategic missteps, including excessive capital expenditures and poor asset utilization. Macellum asserts that fresh leadership is essential for long-term value creation and urges shareholders to reject the current board.

Kohl’s Corporation (NYSE: KSS) has sent a letter to shareholders emphasizing the qualifications of its Board of Directors amid ongoing proposals from Macellum Advisors to change the board composition. The company has added six new independent directors in the last three years and asserts that its board has the necessary skills for effective oversight, particularly in M&A processes. Kohl's urges shareholders to vote for its 13 directors, highlighting concerns over the qualifications of Macellum's nominees, who lack public company experience. The Annual Meeting is set for May 11, 2022.

Macellum Advisors, holding nearly 5% of Kohl’s Corporation (KSS) shares, has expressed concerns regarding the Board’s strategic review process, calling it flawed and lacking transparency. They highlight a significant share price lag, trading 15% below reported offers, and criticize the Board for rejecting credible acquisition interest. Macellum questions the effectiveness of the Board’s capital-intensive plan and its failure to address shareholder concerns. They urge the Board to clarify the status of acquisition bids before the upcoming Annual Meeting.

Kohl’s Corporation (NYSE: KSS) announced a shareholder letter highlighting a transformation aimed at boosting growth and profitability. The Board is engaged in evaluating interest from multiple potential buyers while criticizing Macellum's director nominees as inexperienced. The letter emphasizes substantial progress since initiating a new strategy in October 2020, achieving record EPS and a 146% total shareholder return since then. Kohl’s is urging shareholders to vote for its nominees on the BLUE Proxy Card amid claims of Macellum’s contradictory agenda that lacks value-enhancing proposals.

Macellum Advisors, a significant stakeholder in Kohl’s (NYSE: KSS), is urging shareholders to support their proposed board slate at the upcoming Annual Meeting on May 11, 2022. They criticize the current board for poor performance, including rejecting acquisition offers and implementing unfavorable practices like a poison pill strategy. Despite these concerns, Macellum believes a restructured board could enhance value through credible reviews of the company's direction. Shareholders are encouraged to vote using the WHITE proxy card for Macellum's slate.